Smithbridge Asset Management Inc Abbott Laboratories Transaction History

Smithbridge Asset Management Inc

$573 Million
Q3 2024

A detailed history of Smithbridge Asset Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Smithbridge Asset Management Inc holds 40,368 shares of ABT stock, worth $4.61 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares

40,368

Previous 39,397 2.46%

Holding current value

$4.61 Million

Previous $4.09 Million 12.44%

% of portfolio

0.8%

Previous 0.86%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $97,167 - $114,704	971 Added 2.46%	40,368 $4.6 Million
Q2 2024 Jul 19, 2024	SELL	$100.73 - $112.44 $552,000 - $616,171	-5,480 Reduced 12.21%	39,397 $4.09 Million
Q1 2024 May 03, 2024	SELL	$109.52 - $120.96 $13,251 - $14,636	-121 Reduced 0.27%	44,877 $5.1 Million
Q4 2023 Jan 18, 2024	SELL	$90.19 - $110.4 $35,625 - $43,608	-395 Reduced 0.87%	44,998 $4.95 Million
Q3 2023 Oct 25, 2023	BUY	$95.53 - $114.62 $49,006 - $58,800	513 Added 1.14%	45,393 $4.4 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $55,328 - $61,647	549 Added 1.24%	44,880 $4.89 Million
Q2 2023 Jul 18, 2023	SELL	$100.78 - $112.29 $31,141 - $34,697	-309 Reduced 0.69%	44,331 $4.87 Million
Q1 2023 Apr 20, 2023	BUY	$96.86 - $114.01 $29,929 - $35,229	309 Added 0.7%	44,640 $4.52 Million
Q4 2022 Mar 01, 2023	BUY	$95.06 - $111.52 $47,530 - $55,760	500 Added 1.14%	44,331 $4.87 Million
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $61,732 - $71,475	638 Added 1.48%	43,831 $4.24 Million
Q2 2022 Aug 03, 2022	SELL	$102.07 - $123.37 $2,041 - $2,467	-20 Reduced 0.05%	43,193 $4.69 Million
Q1 2022 Apr 25, 2022	SELL	$114.02 - $139.04 $14,024 - $17,101	-123 Reduced 0.28%	43,213 $5.12 Million
Q4 2021 Jan 24, 2022	BUY	$115.53 - $141.46 $38,009 - $46,540	329 Added 0.76%	43,336 $6.1 Million
Q3 2021 Oct 04, 2021	SELL	$116.66 - $129.06 $47,947 - $53,043	-411 Reduced 0.95%	43,007 $5.08 Million
Q2 2021 Jul 23, 2021	BUY	$105.79 - $124.53 $95,211 - $112,077	900 Added 2.12%	43,418 $5.03 Million
Q1 2021 Apr 06, 2021	BUY	$108.84 - $128.23 $132,784 - $156,440	1,220 Added 2.95%	42,518 $5.1 Million
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $117,390 - $127,921	-1,118 Reduced 2.64%	41,298 $4.52 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $14,570 - $17,695	159 Added 0.38%	42,416 $4.62 Million
Q2 2020 Jul 01, 2020	BUY	$76.57 - $98.0 $76,570 - $98,000	1,000 Added 2.42%	42,257 $3.86 Million
Q1 2020 Apr 13, 2020	SELL	$62.82 - $91.86 $47,806 - $69,905	-761 Reduced 1.81%	41,257 $3.26 Million
Q4 2019 Jan 09, 2020	SELL	$78.51 - $87.4 $45,928 - $51,129	-585 Reduced 1.37%	42,018 $3.65 Million
Q3 2019 Oct 15, 2019	BUY	$81.84 - $88.74 $31,917 - $34,608	390 Added 0.92%	42,603 $3.57 Million
Q2 2019 Jul 09, 2019	BUY	$72.88 - $85.0 $364 - $425	5 Added 0.01%	42,213 $3.55 Million
Q1 2019 Apr 03, 2019	BUY	$66.22 - $80.06 $33,441 - $40,430	505 Added 1.21%	42,208 $3.37 Million
Q4 2018 Jan 15, 2019	SELL	$65.56 - $74.27 $23,470 - $26,588	-358 Reduced 0.85%	41,703 $3.02 Million
Q3 2018 Oct 05, 2018	BUY	$60.81 - $73.36 $96,687 - $116,642	1,590 Added 3.93%	42,061 $3.09 Million
Q2 2018 Jul 18, 2018	SELL	$57.57 - $63.54 $56,706 - $62,586	-985 Reduced 2.38%	40,471 $2.47 Million
Q1 2018 Apr 09, 2018	SELL	$56.27 - $63.62 $82,829 - $93,648	-1,472 Reduced 3.43%	41,456 $2.48 Million
Q4 2017 Jan 18, 2018	BUY	$53.68 - $57.47 $39,293 - $42,068	732 Added 1.73%	42,928 $2.45 Million
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $2.03 Million - $2.26 Million	42,196	42,196 $2.25 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithbridge Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Smithbridge Asset Management Inc with notifications on news.

Account

Smithbridge Asset Management Inc Abbott Laboratories Transaction History